Zeria Pharmaceutical Co., Ltd. (TYO:4559)

Zeria Pharmaceutical Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	24,517	20,323	16,219	11,704	9,793	9,005
Short-Term Investments	-	-	-	-	3	-
Cash & Short-Term Investments	24,517	20,323	16,219	11,704	9,796	9,005
Cash Growth	25.51%	25.30%	38.58%	19.48%	8.78%	11.93%
Receivables	24,899	21,080	17,419	16,153	13,497	13,239
Inventory	16,075	14,489	12,764	11,950	11,104	9,563
Other Current Assets	2,158	1,917	1,801	1,856	2,916	3,213
Total Current Assets	67,649	57,809	48,203	41,663	37,313	35,020
Property, Plant & Equipment	26,185	26,517	24,591	23,139	23,634	23,125
Long-Term Investments	22,193	22,957	20,172	18,165	18,775	16,077
Goodwill	3,753	4,262	5,299	5,830	6,429	7,081
Other Intangible Assets	36,798	38,877	36,631	35,376	35,640	22,767
Long-Term Deferred Tax Assets	-	110	136	108	67	85
Other Long-Term Assets	2	1	2	1	1	-
Total Assets	156,580	150,533	135,034	124,282	121,859	104,155
Accounts Payable	4,512	3,273	1,996	2,049	1,693	1,587
Accrued Expenses	945	1,584	1,554	1,530	1,268	1,221
Short-Term Debt	37,712	38,283	34,890	33,842	44,158	29,705
Current Income Taxes Payable	3,642	1,967	749	458	562	6,851
Other Current Liabilities	10,040	9,411	7,969	6,314	6,076	1,706
Total Current Liabilities	56,851	54,518	47,158	44,193	53,757	41,070
Long-Term Debt	6,419	7,943	14,541	18,385	5,819	5,470
Long-Term Deferred Tax Liabilities	-	6,447	5,190	3,905	3,356	2,554
Other Long-Term Liabilities	7,547	1,339	2,232	1,635	1,441	1,260
Total Liabilities	71,342	70,705	69,355	69,191	65,681	51,477
Common Stock	6,593	6,593	6,593	6,593	6,593	6,593
Additional Paid-In Capital	11,685	11,685	11,685	11,685	11,685	11,685
Retained Earnings	65,497	59,254	53,462	48,860	46,380	44,832
Treasury Stock	-18,266	-18,265	-18,264	-17,593	-14,997	-13,846
Comprehensive Income & Other	19,550	20,355	11,973	5,349	6,350	3,246
Total Common Equity	85,059	79,622	65,449	54,894	56,011	52,510
Minority Interest	179	206	230	197	167	168
Shareholders' Equity	85,238	79,828	65,679	55,091	56,178	52,678
Total Liabilities & Equity	156,580	150,533	135,034	124,282	121,859	104,155
Total Debt	44,131	46,226	49,431	52,227	49,977	35,175
Net Cash (Debt)	-19,614	-25,903	-33,212	-40,523	-40,181	-26,170
Net Cash Per Share	-444.97	-587.64	-751.86	-897.74	-872.14	-560.22
Filing Date Shares Outstanding	44.08	44.08	44.08	44.21	45.36	46.2
Total Common Shares Outstanding	44.08	44.08	44.08	44.41	45.7	46.29
Working Capital	10,798	3,291	1,045	-2,530	-16,444	-6,050
Book Value Per Share	1929.67	1806.31	1484.77	1236.08	1225.66	1134.29
Tangible Book Value	44,508	36,483	23,519	13,688	13,942	22,662
Tangible Book Value Per Share	1009.72	827.66	533.55	308.22	305.09	489.53

Source: S&P Capital IQ. Standard template. Financial Sources.